Cargando…
Cross-Protective Peptide Vaccine against Influenza A Viruses Developed in HLA-A*2402 Human Immunity Model
BACKGROUND: The virus-specific cytotoxic T lymphocyte (CTL) induction is an important target for the development of a broadly protective human influenza vaccine, since most CTL epitopes are found on internal viral proteins and relatively conserved. In this study, the possibility of developing a stra...
Autores principales: | Ichihashi, Toru, Yoshida, Reiko, Sugimoto, Chihiro, Takada, Ayato, Kajino, Kiichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176274/ https://www.ncbi.nlm.nih.gov/pubmed/21949735 http://dx.doi.org/10.1371/journal.pone.0024626 |
Ejemplares similares
-
Emulsified Phosphatidylserine, Simple and Effective Peptide Carrier for Induction of Potent Epitope-Specific T Cell Responses
por: Ichihashi, Toru, et al.
Publicado: (2013) -
Related parameters of affinity and stability prediction of HLA-A*2402 restricted antigen peptides based on molecular docking
por: Huang, Changxin, et al.
Publicado: (2021) -
Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*2402
por: Baba, Toshiyuki, et al.
Publicado: (2010) -
TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice
por: Tanaka, Yuki, et al.
Publicado: (2020) -
Analysis of memory T lymphocyte activity following stimulation with overlapping HLA-A*2402, A*0101 and Cw*0402 restricted CMV pp65 peptides
por: Ghei, Monica, et al.
Publicado: (2005)